CVS To Pay $75M For Admitted Sale Of Meth Ingredient

Law360, New York (October 14, 2010, 5:22 PM EDT) -- CVS Pharmacy Inc. on Thursday agreed to pay the federal government $75 million, admitting it sold pseudoephedrine, a key ingredient in methamphetamine, to criminals in violation of the Controlled Substances Act.

CVS, the country's largest retail pharmacy chain, has until Friday to fork over the money, which stands as the largest civil penalty ever paid under the CSA, the U.S. Attorney's Office for the Central District of California said Thursday.

The company signed a non-prosecution agreement, saving it from criminal charges, in exchange for the penalty...
To view the full article, register now.